Influenza virus A subtype H1N1 is inhibited by methylated β-lactoglobulin

Journal of Dairy Research

Volumn 77, Issue 4, 2010, Pages 411-418

  Sitohy, Mahmoud ^a,c   Scanu, Michela ^a   Besse, Bernard ^b   Mollat, Claudine ^b   Billaudel, Sylviane ^b   Haertlé, Thomas ^a   Chobert, Jean Marc ^a  

^a INRA   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Zagazig University   (Egypt)

Author keywords

Lactoglobulin; Esterification; H1N1; Influenza virus; Inhibition

Indexed keywords

LACTOGLOBULIN; VIRUS RNA;

ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; CHEMISTRY; DOG; DRUG EFFECT; HEMAGGLUTINATION; INFLUENZA VIRUS A H1N1; METHYLATION; PHYSIOLOGY; ULTRASTRUCTURE; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELL SURVIVAL; DOGS; HEMAGGLUTINATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; LACTOGLOBULINS; METHYLATION; RNA, VIRAL; VIRUS REPLICATION;

INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

EID: 77958461183     PISSN: 00220299     EISSN: 14697629     Source Type: Journal    
DOI: 10.1017/S0022029910000592     Document Type: Article

References (30)

1. Baba M, Schols D, Pauwels R, Balzarini J & De Clercq E 1988 Fuschin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochemical and Biophysical Research Communication 155 1404-1411
2. Baccam P, Beauchemin C, Macken CA, Hayden FG & Perelson AS 2006 Kinetics of influenza A virus infection in humans. Journal of Virology 80 7590-7599
3. Balzarini J, Mitsuya H, De Clercq E & Broder S 1986 Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochemical and Biophysical Research Communication 136 64-71
4. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dilen PM & van der Noordaa J 1990 Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 28 495-503
5. Boulo S, Akarsu H, Ruigrok RW & Baudin F 2007 Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes. Virus Research 124 12-21
6. Bourmakina SV & Garci-Sastre A 2005 The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells. Journal of Virology 79 7926-7932
7. De Clercq E 2009 The next ten stories on antiviral drug discovery (Part E) : Advents, advances, and adventures. Medicinal Research Review. DOI 10.1002/med.20179
8. Donald HB & Isaacs A 1954 Counts of influenza virus particles. Journal of General Microbiology 10 457-464
9. Hariton-Gazal E, Rosenbluh J, Graessmann A, Gilon C & Loyter A 2003 Direct translocation of histone molecules across cell membranes. Journal of Cell Science 116 4577-4586
10. Horne RW & Wildy P 1979 An historical account of the development and applications of the negative staining technique to the electron microscopy of viruses. Journal of Microscopy 117 103-122
11. Huang T-S, Palese P & Krystal M 1990 Determination of influenza virus proteins required for genomic replication. Journal of Virology 64 5669-5673
12. Invitrogene life technologies 2003 SuperScript. III One-Step RT-PCR System with Platinum® Taq DNA Polymerase, Cat. No. 12574-018
13. Mailliart P & Ribadeau Dumas B 1988 Preparation of β-lactoglobulin and α-lactalbumin-free proteins from whey retentate by sodium chloride salting out at low pH. Journal of Food Science 53 743-752
14. Mc Kimm-Breschkin J, Sahasrabudhe A, Bilck T & McDonald M 2001 Mechanism of resistance of influenza virus to neuraminidase inhibitors. International Congress Series 1219 855-861
15. Mc Kimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F & Zambon M 2003 Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrobial Agents and Chemotherapy 47 2264-2272
16. Murayama R, Harada Y, Shibata T, Kuroda K, Hayakawa S, Shimizu K & Tanaka T 2007 Influenza A virus non-structural protein 1 (NS1) interacts with cellular multifunctional nucleolin during infection. Biochemical and Biophysical Research Communication 362 880-885
17. Neumann G, Noda T, Kawaoka Y 2009 Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459 931-939
18. Peiris JSM, Yu WC, Leung CW, Cheung, CY, Ng WF, Nicholls, JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y 2004 Re-emergence of fatal human influenza A subtype H5N1 disease. The Lancet 363 617-619
19. Poole E, Elton D, Medcalf L & Digard P 2004 Functional domains of influenza A virus PB2 protein: Identification of NP- and PB1-binding sites. Virology 321 120-133
20. Rachakonda PS, Veit M, Korte T, Ludwig K, Bottcher C, Huang Q, Schmidt MFG & Herrmann A 2007 The relevance for the stability of the influenza virus hemagglutinin. FASEB Journal 21 995-1002
21. Sitohy MZ, Chobert J-M & Haertlé T 2001 Simplified short-time method for the esterification of milk proteins. Milchwissenschaft 56 127-131
22. Sitohy M, Chobert J-M & Haertlé T 2005 Esterified whey proteins can protect Lactococcus lactis against bacteriophage infection. Comparison with the effect of native basic proteins and L-polylysines. Journal of Agricultural and Food Chemistry 53 3727-3734
23. Sitohy M, Chobert J-M, Karwowska U, Gozdzicka-Jozefiak A & Haertlé T 2006 Inhibition of bacteriophage M13 replication with esterified milk proteins. Journal of Agricultural and Food Chemistry 54 3800-3806
24. Sitohy M, Billaudel S, Haertlé T & Chobert J-M 2007 Antiviral activity of esterified α-lactalbumin and β-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines. Journal of Agricultural and Food Chemistry 55 10214-10220
25. Sitohy M, Chobert J-M, Dalgalarrondo M, Nowoczin M, Besse B, Billaudel S & Haertlé T 2008 The effect of bovine whey proteins on the ability of Poliovirus and Coxsackie virus to infect Vero cells cultures. International Dairy Journal 18 658-668
26. Sitohy M, Besse B, Billaudel S, Haertlé T & Chobert J-M 2010 Anti-viral action of methylated β-lactoglobulin on the human influenza virus A subtype H3N2. Probiotics and Antimicrobial Proteins 2 104-111
27. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Lohman K, Daum LT & Suaez DL 2002 Development of a real-time reverse transcriptase PCR assay for Type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. Journal of Clinical Microbiology 40 3256-3260
28. Tirabassi RS & Enquist LW 1998 Role of envelop protein in gE endocytosis in the pseudorabies virus life cycle. Journal of Virology 72 4571-4579
29. WHO 2009 (http://www.who.int/csr/disease/swineflu/notes/h1n1-antiviral- resistance-20090708/ en/index.html)
30. Yamaguchi M, Danev R, Nishiyama K, Sugawara K & Nagayama K 2008 Zernike phase contrast electron microscopy of ice-embedded influenza A virus. Journal of Structural Biology 162 271-276